Investing in tomorrow's medicine

 

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.

Launch video

News

Mérieux Equity Partners has entered the capital of Addmedica – as a reference shareholder – in order to accelerate the company’s growth in France and internationally

11/12/2019

Inscripta Raises $125M in Series D Financing

10/12/2019

New funding brings total amount raised to $259.5M and will be used to accelerate commercialization of revolutionary Digital Genome Engineering Platform.

Merieux Equity Partners co-invests alongside IK Investment Partners in Mabtech

26/11/2019

Mabtech's products are used by researchers and companies worldwide to study immune responses in cancer, allergy, infectious diseases and monitor vaccine trials.

Key figures

30
Supported Companies
16
Team
600
Assets Under Management
(€ million)
3
Offices (Lyon, Paris, Boston)